A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction
NCT ID: NCT02027909
Last Updated: 2018-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
8 participants
OBSERVATIONAL
2011-11-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Medtronic pacemakers provide rate response pacing by utilizing dual zone programming to specify an "activities of daily living" (ADL) response rate and an "exertion" response rate. There is much data to support the target heart rate for an exercise response but the data to support the programming of the ADL rate is lacking.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Allometric-Pace Study
NCT05766462
Efficacy Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart Failure
NCT02145351
Minimizing Ventricular Pacing
NCT01611389
Optimal Pacing Rate for Cardiac Resynchronization Therapy
NCT06445439
Comparison of Physiologic Response With Rate Adaptive Pacing Driven by Minute Ventilation and Accelerometer
NCT02003378
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Unpublished Holter data from our center indicates that the ADL rate for most patients in our practice is between 50-70bpm rather than 95bpm. Moreover, this increased ADL rate may impact diastolic filling times and adversely impact cardiac output.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Therapy group one
Lower rate of 60 bpm and out of the box rate response settings of an ADL Rate of 95 bpm and rate profile optimization on with the only change being adjusting the activity threshold from med/low to low.
Reprogramming dual chamber pacemaker
Reprogramming rate response feature in the Medtronic pacemaker to each arm with crossover
Therapy group two
Rate response programming will be determined by an exercise test consisting of a 2 minute hall walk will be performed at the 2 week follow up and set points will be manually adjusted to achieve an ADL rate of 95 bpm. Rate Profile Optimization will be turned off. Activity threshold is programmed to low.
Reprogramming dual chamber pacemaker
Reprogramming rate response feature in the Medtronic pacemaker to each arm with crossover
Therapy group three
Lower rate of 60 bpm and the ADL rate based upon 220- age x 55%. Activity threshold is programmed to low. Rate Profile Optimization will be turned ON.
Reprogramming dual chamber pacemaker
Reprogramming rate response feature in the Medtronic pacemaker to each arm with crossover
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reprogramming dual chamber pacemaker
Reprogramming rate response feature in the Medtronic pacemaker to each arm with crossover
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sinus node dysfunction
* New implantation of a dual chamber pacemaker due to symptomatic sinus dysfunction or chronotropic incompetence defined as exercise heart rate less than 100 beats per minute
Exclusion Criteria
* Age less than 60 or greater than 95 years
* EF less than 45%
* Patients that are not ambulatory
* Persistent atrial fibrillation (atrial fibrillation lasting greater than 7 days)
* Permanent atrial fibrillation (atrial fibrillation lasting great than 1 year)
60 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Arun Rao
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arun Rao
Arun Rao, MD. FACC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arun Rao, MD
Role: PRINCIPAL_INVESTIGATOR
Wellmont CVA Heart Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wellmont CVA Heart Institute
Kingsport, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lau CP, Leung SK. Clinical usefulness of rate adaptive pacing systems: what should we assess? Pacing Clin Electrophysiol. 1994 Dec;17(12 Pt 1):2233-5. doi: 10.1111/j.1540-8159.1994.tb02370.x. No abstract available.
Lau CP, Tai YT, Leung WH, Wong CK, Lee P, Chung FL. Rate adaptive pacing in sick sinus syndrome: effects of pacing modes and intrinsic conduction on physiological responses, arrhythmias, symptomatology and quality of life. Eur Heart J. 1994 Nov;15(11):1445-55. doi: 10.1093/oxfordjournals.eurheartj.a060413.
Oto MA, Muderrisoglu H, Ozin MB, Korkmaz ME, Karamehmetoglu A, Oram A, Oram E, Ugurlu S. Quality of life in patients with rate responsive pacemakers: a randomized, cross-over study. Pacing Clin Electrophysiol. 1991 May;14(5 Pt 1):800-6. doi: 10.1111/j.1540-8159.1991.tb04110.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRIPS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.